The human UTY gene encodes a novel HLA-B8-restricted H-Y antigen.
about
The human cathepsin H gene encodes two novel minor histocompatibility antigen epitopes restricted by HLA-A*3101 and -A*3303Minor histocompatibility antigen DBY elicits a coordinated B and T cell response after allogeneic stem cell transplantationAntibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remissionDetection of a potent humoral response associated with immune-induced remission of chronic myelogenous leukemiaIdentification of a polymorphic gene, BCL2A1, encoding two novel hematopoietic lineage-specific minor histocompatibility antigensThe immunogenicity of a new human minor histocompatibility antigen results from differential antigen processingH-Y Antigen Incompatibility Not Associated with Adverse Immunologic Graft Outcomes: Deceased Donor Pair Analysis of the OPTN DatabaseA novel approach to identify antigens recognized by CD4 T cells using complement-opsonized bacteria expressing a cDNA library.A uniform genomic minor histocompatibility antigen typing methodology and database designed to facilitate clinical applications.C19orf48 encodes a minor histocompatibility antigen recognized by CD8+ cytotoxic T cells from renal cell carcinoma patients.Donor-recipient mismatch for common gene deletion polymorphisms in graft-versus-host diseaseDiverse patterns of T-cell response against multiple newly identified human Y chromosome-encoded minor histocompatibility epitopes.Minor histocompatibility antigens and the maternal immune response to the fetus during pregnancyTherapy of relapsed leukemia after allogeneic hematopoietic cell transplantation with T cells specific for minor histocompatibility antigens.Association of Y chromosome haplogroup I with HIV progression, and HAART outcome.Secondary recurrent miscarriage and H-Y immunity.H-Y antibody titers are increased in unexplained secondary recurrent miscarriage patients and associated with low male : female ratio in subsequent live births.Leukemia vaccines.Adoptive transfer of unselected or leukemia-reactive T-cells in the treatment of relapse following allogeneic hematopoietic cell transplantation.Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors.Occurrence and Impact of Minor Histocompatibility Antigens' Disparities on Outcomes of Hematopoietic Stem Cell Transplantation from HLA-Matched Sibling DonorsInvited review: sex-based differences in gene expression.Minor H antigens: genes and peptides.T-cell therapy of leukemia.Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemiaAdoptive cellular therapy: a therapeutic reality?Minor histocompatibility antigens--targets of graft versus leukemia responses.The immunogenomics of minor histocompatibility antigens.Defining genetic risk for graft-versus-host disease and mortality following allogeneic hematopoietic stem cell transplantation.Clinical impact of H-Y alloimmunityCombined CD4 T-cell and antibody response to human minor histocompatibility antigen DBY after allogeneic stem-cell transplantationMinor histocompatibility antigens are expressed in syncytiotrophoblast and trophoblast debris: implications for maternal alloreactivity to the fetus.Graft-versus-leukemia effects associated with detectable Wilms tumor-1 specific T lymphocytes after allogeneic stem-cell transplantation for acute lymphoblastic leukemia.T cell-mediated graft-versus-leukemia reactions after allogeneic stem cell transplantation.Effect of MHC and non-MHC donor/recipient genetic disparity on the outcome of allogeneic HCTA human minor histocompatibility antigen resulting from differential expression due to a gene deletionAssociation of disparities in known minor histocompatibility antigens with relapse-free survival and graft-versus-host disease after allogeneic stem cell transplantationDDX3Y encodes a class I MHC-restricted H-Y antigen that is expressed in leukemic stem cellsMinor histocompatibility antigens as targets for immunotherapy using allogeneic immune reactions.Targeting minor histocompatibility antigens in graft versus tumor or graft versus leukemia responses.
P2860
Q24296246-B096B752-4C3E-4CAF-BEFB-13547A867246Q24537575-E2F53D01-0A3C-49CA-AF83-A93020C70A5BQ24539030-136AA35B-5A85-41F4-AB9D-A070265D17A8Q24604091-5B39025D-B481-43A4-A034-5009F31AEDDBQ24673417-DF5FFFD9-2A05-4EF1-A913-6416B7B4950CQ24675797-1D88E8CF-67BF-4CFA-BF03-F60C1F27C1CAQ30430243-22DB6BA2-14F8-44D1-9ED5-5F6FE2D5E0A0Q33208694-A9492BDF-A568-4FB7-8438-E1FF47E461B9Q33267303-A6498B68-B195-479D-9B4D-727646895F56Q33359498-B1245E56-0A23-4FD3-9874-DFDCB576E1FCQ33583414-C28DE7CE-6A29-4F63-976D-0BB408E50861Q33709766-96D515CC-7E97-4659-9D5E-626681832770Q33723635-48F594D5-C338-4B1B-89E0-BD9712984607Q33849560-C9A7413D-A00D-4CD0-87CC-00925F1686A3Q33911951-E428DD03-9B5F-44B6-9B09-BEE5FC30D945Q34177424-FE780BD0-B477-4D13-86CA-BD0B185FA016Q34202524-6B38C78A-1B5D-4A91-9A32-5A72E5009BFCQ34214817-2B107055-A55C-4238-B98D-48FF514E822FQ34279672-3D7234BF-F74F-44D0-B072-27DBF7BA3FC6Q34312702-326DEDC9-EFD4-49CF-A0C8-39AD865C92A1Q34314427-76678C55-66F9-4302-A515-EAE74AF725DDQ34407680-36120AF2-E60E-4AD0-B3AF-19ADF3A01652Q34553895-85391E4D-7407-47DE-8ECD-037E6352A82DQ34608658-ECA1741C-FC6E-4FEE-BB42-9B44CE18BE4BQ34808353-E47E8204-6274-403A-95ED-7E3D4E2FFED2Q34875170-78363290-9A8F-44C4-96DC-E592C3DE43F3Q34996292-A67B5475-90E4-43A3-A5D5-1B2BDD3A4FBAQ35030963-AFCB7770-D6CC-44B4-ACB5-5196E9EAD298Q35224947-E667D7EB-77BE-4D91-98F6-1C67253698C1Q35235186-43D5606E-0C2C-4A69-9101-D8E425E8A6C4Q35687151-50320021-6F45-4E5B-90A4-1F2460A32ACCQ35917686-E864C470-87A1-4B45-88AC-972A257E623BQ35990687-3ABA0C5F-469A-47BB-8710-2233BF960C2AQ36123756-21F2089F-5635-4A42-8F24-395FB38C53ECQ36305321-878CA3EC-F4E4-4E41-8ECF-D2D42D3B05D7Q36370375-860A685D-7BB6-4D66-B145-B27D9DB7F05EQ36556944-E7C46103-B34B-45D4-B524-5FF0E7515582Q36591409-8F057AC6-0B77-403F-89E8-4B64AAD4FA4FQ36830199-874903F1-32FB-4CB0-9D43-F8D4CA79C758Q36994811-4907AA71-C334-4752-806F-AB2F2F08227A
P2860
The human UTY gene encodes a novel HLA-B8-restricted H-Y antigen.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
The human UTY gene encodes a novel HLA-B8-restricted H-Y antigen.
@ast
The human UTY gene encodes a novel HLA-B8-restricted H-Y antigen.
@en
type
label
The human UTY gene encodes a novel HLA-B8-restricted H-Y antigen.
@ast
The human UTY gene encodes a novel HLA-B8-restricted H-Y antigen.
@en
prefLabel
The human UTY gene encodes a novel HLA-B8-restricted H-Y antigen.
@ast
The human UTY gene encodes a novel HLA-B8-restricted H-Y antigen.
@en
P2093
P1476
The human UTY gene encodes a novel HLA-B8-restricted H-Y antigen
@en
P2093
C Disteche
K A Stankey
P Chandler
P D Greenberg
S R Riddell
P304
P356
10.4049/JIMMUNOL.164.5.2807
P407
P577
2000-03-01T00:00:00Z